title: ALS endpoints. Survival.
authors.affiliation: Clinical Affaires, Regeneron Pharmaceuticals, Inc., New York, USA.
authors.forename: J
authors.initials: J
authors.lastname: Cedarbaum
mesh_terms: D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy / Q000401:mortality*; D002986:Clinical Trials as Topic / Q000379:methods*; D023381:Endpoint Determination / Q000379:methods*; D006801:Humans; D015201:Meta-Analysis as Topic; D013997:Time Factors